Author:
Meyer-Monard S,Parlier V,Passweg J,Mühlematter D,Hess U,Bargetzi M,Kühne T,Cabrol C,Gratwohl A,Jotterand M,Tichelli A
Publisher
Springer Science and Business Media LLC
Subject
Oncology,Cancer Research,Hematology
Reference19 articles.
1. Look AT . Oncogenic transcription factors in the human acute leukemias. Science 1997; 278: 1059–1064.
2. Jaffe ES, Harris NL, Stein H, Vardiman JW . World Health Organisation Classification of Tumors. Pathology and Genetics of Haematopoietic and Lymphoid Tissues. Lyon: IARC Press, 2001.
3. Druker BJ . Imatinib as a paradigm of targeted therapies. Adv Cancer Res 2004; 91: 1–30.
4. Tallman MS, Rowe JM . Acute promyelocytic leukemia: a paradigm for differentiation therapy with retinoic acid. Blood Rev 1994; 8: 70–78.
5. Byrd JC, Mrozek K, Dodge RK, Carroll AJ, Edwards CG, Arthur DC et al. Pretreatment cytogenetic abnormalities are predictive of induction success, cumulative incidence of relapse, and overall survival in adult patients with de novo acute myeloid leukemia: results from Cancer and Leukemia Group B (CALGB 8461). Blood 2002; 100: 4325–4336.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献